Axios Pro Exclusive Content

GSK to acquire cancer treatment from Chimagen Biosciences for up to $750 million

Sep 15, 2026
Illustration of a set of shaking hands with shapes and lines in the background

Illustration: Sarah Grillo/Axios

What to read next